HBAN

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Nscale’s IPO reveals $140.6m revenue against $1.02bn first-half loss

Anthropic is reportedly considering another advanced Claude model as competition with OpenAI intensifies across enterprise artificial-intelligence workloads. Representative image.

Anthropic weighs another Claude model as OpenAI Astra intensifies enterprise AI race

Arista Networks is expanding its EOS-based networking platform across 1.6-terabit Ethernet AI fabrics, hyperscale data centers, CloudVision and enterprise connectivity as artificial intelligence reshapes network architecture. Representative image.

Arista Networks company profile: How EOS and Ethernet are powering its AI data center expansion

Eli Lilly’s retatrutide moves closer to a planned 2027 U.S. filing after completing its core Phase 3 programme for obesity, knee pain and sleep apnea. Representative image.

Retatrutide development: Phase 3 results, 2027 FDA filing, TRIUMPH trials and what comes next

Huntington Bancshares gets final regulatory approval to absorb Cadence Bank in $7.4B all-stock deal

Find out how Huntington’s $7.4B merger with Cadence Bank reshapes U.S. regional banking and why Texas and Mississippi are now strategic battlegrounds.

μFR system
αvβ6-integrin
α4β7 integrin
Þorgerður Katrín Gunnarsdóttir
Zywie Ventures
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynyz
ZYNRELEF

December 23, 2025